FindMyRecallSubscribe
Class I: serious health riskTerminated

Bristol-myers Squibb BiCNU Recall

BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Be…

Bristol-myers Squibb Company · New Brunswick, NJ

Risk level
Class I
Reported by FDA
Oct 31, 2012
Recall ID
D-012-2013
Check your lot numberHow we source this data

Summary

Bristol-myers Squibb recalled BiCNU starting Aug 29, 2012. The FDA classified it as Class I (serious health risk) and published enforcement report D-012-2013 on Oct 31, 2012. Reason: Superpotent (Single Ingredient) Drug: All BiCNU lots within expiration which contain carmustine vial lots manufactured by BenVenue Laboratories (BVL) are being recalled because of an overfilled vial discovered during stability testing for a single carmustine lot. Status: Terminated.

Why it was recalled

Superpotent (Single Ingredient) Drug: All BiCNU lots within expiration which contain carmustine vial lots manufactured by BenVenue Laboratories (BVL) are being recalled because of an overfilled vial discovered during stability testing for a single carmustine lot.

Product description

BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc. Bedford, OH 44146 Diluent manufactured by: Luitpold Pharmaceuticals, Inc. Shirley, NY 11967 Distributed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA Made in USA NDC 0015-3012-18 NDC 0015-3012-60

Lot numbers, UPCs & expiration codes

Kit/Vial Lot #: (9L7003A/1803607), Exp 11/12; (9H4209A/1803608), Exp 01/13; (9H4211A/1843251), Exp 02/13; (0B7004A/1843251), Exp 04/13; (0B7005A/2011804), (0E7004A/2011804), Exp 05/13; (0E7006A/2055384), Exp 09/13; (0J7007A/2064024), (1A7005A/2064024), Exp 01/14; (1C7006A/2106210), Exp 04/14

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-012-2013
Classification
Class I
Status
Terminated
Recall initiated
Aug 29, 2012
FDA report date
Oct 31, 2012
Quantity
31,481 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Bristol-myers Squibb Company

Original FDA data

Every field from FDA enforcement report D-012-2013, exactly as published.

Show all FDA fields
City
New Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
63043
Address
1 Squibb Dr
Code information
Kit/Vial Lot #: (9L7003A/1803607), Exp 11/12; (9H4209A/1803608), Exp 01/13; (9H4211A/1843251), Exp 02/13; (0B7004A/1843251), Exp 04/13; (0B7005A/2011804), (0E7004A/2011804), Exp 05/13; (0E7006A/2055384), Exp 09/13; (0J7007A/2064024), (1A7005A/2064024), Exp 01/14; (1C7006A/2106210), Exp 04/14
Postal code
08901
Report date
Oct 31, 2012
Product type
Drugs
Recall number
D-012-2013
Classification
Class I
Recalling firm
Bristol-myers Squibb Company
Product quantity
31,481 kits
Termination date
Aug 12, 2013
Reason for recall
Superpotent (Single Ingredient) Drug: All BiCNU lots within expiration which contain carmustine vial lots manufactured by BenVenue Laboratories (BVL) are being recalled because of an overfilled vial discovered during stability testing for a single carmustine lot.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc. Bedford, OH 44146 Diluent manufactured by: Luitpold Pharmaceuticals, Inc. Shirley, NY 11967 Distributed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA Made in USA NDC 0015-3012-18 NDC 0015-3012-60
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Aug 29, 2012
Initial firm notification
Letter
Center classification date
Oct 24, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-012-2013, published Oct 31, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls